June 1, 2020 / 11:12 AM / a month ago

BRIEF-Astrazeneca - Brilinta Approved In U.S. To Reduce Risk Of Stroke In Patients With Coronary Artery Disease

June 1 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA - BRILINTA HAS BEEN APPROVED IN U.S. TO REDUCE RISK OF A FIRST HEART ATTACK OR STROKE IN HIGH-RISK PATIENTS WITH CORONARY ARTERY DISEASE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below